Loading stock data...

Zenotech Laboratories Limited

BSE: ZENOTECH

BSE
47.37 1.18 (2.55%)

Prev Close

46.19

Open Price

45.7

Volume

7,905

Today Low / High

45.7 / 48

52 WK Low / High

43.85 / 72.87

Range

45 - 50

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 47.37, reflecting a change of 1.18 (2.55467%). The expected target range on the BSE is 45 - 50. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

01 Jan 46.99 -1.70%
31 Dec 46.00 0.41%
30 Dec 46.60 -1.59%
29 Dec 45.01 2.22%
26 Dec 45.32 0.66%
24 Dec 46.35 -0.24%
23 Dec 46.25 0.24%
22 Dec 44.26 3.12%
19 Dec 45.00 -1.71%
18 Dec 45.00 -1.36%
17 Dec 46.09 -2.08%
16 Dec 46.68 -0.39%
15 Dec 47.25 -1.21%
12 Dec 47.00 -1.85%
11 Dec 45.56 2.13%
10 Dec 46.80 -2.65%
09 Dec 46.54 -2.69%
08 Dec 46.80 -0.56%

Zenotech Laboratories Limited Graph

Zenotech Laboratories Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Zenotech Laboratories Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 47.37, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 47.37 47.84 43.06 - 52.63
48.32 38.65 - 57.98
48.79 34.15 - 63.43
Bearish Scenario 47.37 46.90 42.21 - 51.59
46.42 37.14 - 55.71
45.95 32.16 - 59.73

Overview of Zenotech Laboratories Limited

ISIN

INE486F01012

Industry

Medical - Pharmaceuticals

Vol.Avg

9,216

Market Cap

2,819,001,936

Last Dividend

0

Official Website

Visit Website

IPO Date

2004-03-01

DCF Diff

-100.36

DCF

151

Financial Ratios Every Investor Needs

Stock Rating Details for ZENOTECH

Metric Value Recommendation
Overall Rating B- Neutral
DCF Score 5 Strong Buy
ROE Score 3 Neutral
ROA Score 3 Neutral
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 2 Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 38.98 Cr 0.84 Cr 39.68 Cr 1.0182 0.00 Cr 12.38 Cr 3.42 Cr 5.61 Cr 0.92 15.73 Cr 0.1440
2024-03-31 36.76 Cr 3.09 Cr 33.67 Cr 0.9160 0.00 Cr 9.46 Cr 24.24 Cr 8.30 Cr 1.36 18.23 Cr 0.2257
2023-03-31 38.35 Cr 3.57 Cr 34.78 Cr 0.9069 0.00 Cr 0.97 Cr 9.59 Cr 11.59 Cr 1.90 21.79 Cr 0.3021
2022-03-31 32.49 Cr 2.55 Cr 29.94 Cr 0.9214 0.00 Cr 0.89 Cr 22.78 Cr 22.18 Cr 3.63 17.92 Cr 0.6825
2021-03-31 19.37 Cr 2.39 Cr 16.98 Cr 0.8765 0.00 Cr 0.67 Cr -3.15 Cr -1.22 Cr -0.20 6.79 Cr -0.0627

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 26.70 Cr 111.03 Cr 14.90 Cr 96.1308 Cr 0.00 Cr -26.70 Cr 0.00 Cr 64.44 Cr 0.00 Cr 0.00 Cr 1.45 Cr 12.5870 Cr
2024-03-31 19.69 Cr 106.21 Cr 15.66 Cr 90.5416 Cr 0.00 Cr -19.69 Cr 0.86 Cr 67.54 Cr 0.00 Cr 0.00 Cr 1.38 Cr 13.5231 Cr
2023-03-31 11.14 Cr 100.87 Cr 18.60 Cr 82.2701 Cr 0.00 Cr -11.14 Cr -0.03 Cr 70.36 Cr 0.00 Cr 0.00 Cr 1.35 Cr 16.6070 Cr
2022-03-31 2.41 Cr 94.08 Cr 23.44 Cr 70.6401 Cr 6.00 Cr 3.59 Cr 0.13 Cr 71.19 Cr 0.00 Cr 0.00 Cr 0.78 Cr 15.5755 Cr
2021-03-31 2.46 Cr 85.84 Cr 37.44 Cr 48.4082 Cr 20.66 Cr 18.20 Cr 0.09 Cr 76.41 Cr 0.00 Cr 0.00 Cr 0.00 Cr 14.9472 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 9.4884 Cr 15.2887 Cr 0.0000 Cr 5.6252 Cr 24.7594 Cr 26.5751 Cr -3.8632 Cr 5.6129 Cr 0.0000 Cr 0.0000 Cr 0.8402 Cr
2024-03-31 12.7677 Cr -22.0998 Cr 0.0000 Cr 8.5342 Cr -9.3267 Cr 1.8157 Cr -4.2335 Cr 8.2987 Cr 0.0000 Cr 0.0000 Cr -0.8402 Cr
2023-03-31 20.6642 Cr -5.8244 Cr -6.1122 Cr 14.4325 Cr 8.7276 Cr 11.1424 Cr -6.2317 Cr 14.5023 Cr -6.0000 Cr 0.0000 Cr 0.0608 Cr
2022-03-31 17.6674 Cr -1.8389 Cr -15.8714 Cr 15.7299 Cr -0.0429 Cr 2.4148 Cr -1.9375 Cr 9.9013 Cr -14.6562 Cr 0.0000 Cr 0.0011 Cr
2021-03-31 5.7410 Cr -4.8178 Cr 0.4525 Cr 0.8295 Cr 1.3757 Cr 2.4577 Cr -4.9115 Cr -1.2151 Cr 2.0000 Cr 0.0000 Cr 0.0322 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-09-30 10.23 Cr 10.73 Cr 10.23 Cr 1.0000 0.51 Cr -0.84 Cr -0.14 3.04 Cr -0.0818
2025-06-30 9.64 Cr 8.95 Cr 8.64 Cr 0.8959 0.69 Cr 0.99 Cr 0.16 3.05 Cr 0.1026
2025-03-31 12.13 Cr 5.39 Cr 6.74 Cr 0.5559 2.74 Cr 1.23 Cr 0.20 4.98 Cr 0.1014
2024-12-31 10.22 Cr 0.20 Cr 10.02 Cr 0.9802 2.11 Cr 1.69 Cr 0.28 4.87 Cr 0.1656
2024-09-30 9.76 Cr 4.90 Cr 4.87 Cr 0.4984 0.66 Cr 1.35 Cr 0.22 4.10 Cr 0.1380

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 31.61 Cr 1.98 Cr 33.59 Cr 3.52 Cr 0.00 Cr 37.92 Cr 65.00 Cr 110.92 Cr 14.65 Cr
2025-06-30 0.00 Cr 0.00 Cr 26.70 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -96.13 Cr
2025-03-31 26.70 Cr 0.00 Cr 26.70 Cr 7.45 Cr 0.00 Cr 35.99 Cr 64.44 Cr 111.03 Cr 14.90 Cr
2024-12-31 0.00 Cr 0.00 Cr 21.92 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -93.17 Cr
2024-09-30 1.90 Cr 21.63 Cr 21.92 Cr 5.30 Cr 0.63 Cr 30.45 Cr 65.82 Cr 107.92 Cr 14.76 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 0.99 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 1.23 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 1.69 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 1.35 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 1.29 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
2017-06-01 June 01, 17 1053:1000

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹806.70 ₹96,616,600,363.00 ₹121,137.00

Key Executives

Chief Executive Officer
Sachin Laxmanappa Gavandare

Gender: Not Specified

Year Born:

Company Secretary & Compliance Officer
Abdul Gafoor Mohammad

Gender: male

Year Born: 1980

Head of Production
Bijaya Dora

Gender: male

Year Born:

Chief Financial Officer
Kachappilly Varghese Poly

Gender: male

Year Born: 1970

Head of HR & Admin
K. Srinivas Reddy

Gender: male

Year Born:

Head of Production Biotech
Manohar Pawar

Gender: male

Year Born:

Head of Quality
Nitesh Rasiklal Sheth

Gender: male

Year Born:

Head of QA Biotech
Praveen Veeravelli

Gender: male

Year Born:

Head of Engineering
Ramesh Kumar

Gender: male

Year Born:

FAQs about Zenotech Laboratories Limited

Who is the CEO of the company?

The CEO is Sachin Laxmanappa Gavandare.

What is the current market price of the stock?

The current price is ₹46.19.

What is the 52-week price range?

The range is ₹43.85-72.87.

What is the market capitalization of the company?

The market capitalization is ₹281.90 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 89.73.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Zenotech Laboratories Limited (ISIN: INE486F01012) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹281.90 crores and an average daily volume of 9,216 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.